SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-001558
Filing Date
2020-01-06
Accepted
2020-01-06 16:37:00
Documents
1
Period of Report
2020-01-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm201246-4_4.html 4  
1 OWNERSHIP DOCUMENT tm201246-4_4.xml 4 6636
  Complete submission text file 0001104659-20-001558.txt   8128
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Issuer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACURA PHARMACEUTICALS, INC. 660 N. NORTH COURT PALATINE IL 60067
Business Address
Brzeczko Albert W (Reporting) CIK: 0001455740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10113 | Film No.: 20510244